AstraZeneca and Daiichi Sankyo have moved swiftly to file for FDA approval of a second indication for their TROP2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd), this time for ...
The clock has started ticking in the EU on two marketing applications for AstraZeneca and Daiichi Sankyo’s TROP2-targeting antibody-drug conjugate datopotamab deruxtecan in breast and lung cancer. The ...
Use one of these 6 tried & tested Vimeo coupon codes and save on the all-in-one video-sharing platform. All coupon content is created by Tom’s Guide. We may earn a commission if you buy through our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback